Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,189
datasets available to search
ShareScore release 0.8.0
Dataset results
8,189 results for “Lung cancer”
A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01000480. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05005273. IPD Sharing: YES. Countries: 12. Publications: 0.
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)
ClinicalTrials.gov study NCT00126451. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
ClinicalTrials.gov study NCT01443078. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy
ClinicalTrials.gov study NCT00084487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04206787. IPD Sharing: YES. Countries: 1. Publications: 0.
Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)
ClinicalTrials.gov study NCT02996214. IPD Sharing: NO. Countries: 0. Publications: 1.
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00481078. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00356122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
ClinicalTrials.gov study NCT02785939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00406276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01263782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT02044380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
ClinicalTrials.gov study NCT06790303. IPD Sharing: YES. Countries: 3. Publications: 0.
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01438307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01248247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00064350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT02900742. IPD Sharing: NO. Countries: 0. Publications: 1.
A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), Aft
ClinicalTrials.gov study NCT01853878. IPD Sharing: YES. Countries: 9. Publications: 0.
A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT06530797. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.